Biotechnology
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024. Andrew Kelly | Reuters Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company’s Covid products topped expectations and its broad cost-cutting efforts took […]
Read More
Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
Sopa Images | Lightrocket | Getty Images Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street’s expectations, as the company temporarily paused shipments of a key vaccine into China. The pharmaceutical giant anticipates 2025 sales of $64.1 billion to $65.6 billion, lower than the $67.31 billion that analysts surveyed by […]
Read More
Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
Shana Novak | Stone | Getty Images President Donald Trump’s steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S., raise healthcare costs for patients and threaten cash-strapped generic drugmakers, some drug trade groups warn. Trump on Saturday announced he would impose a 25% tariff on nearly all goods shipped […]
Read More
Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales
An office building designed by Frank O. Gehry at the Novartis AG headquarters campus in Basel, Switzerland. Bloomberg | Getty Images Swiss pharmaceutical giant Novartis on Friday reported better-than-expected sales in the fourth quarter, but falling short of its own guidance over the full-year stretch. Fourth-quarter net sales rose 16% on a constant currency basis […]
Read More
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters The Food and Drug Administration on Thursday approved Vertex Pharmaceuticals’ non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. Vertex is now the first drugmaker in decades to gain U.S. […]
Read More
RFK Jr. stumbles over basics of Medicare, Medicaid during Senate confirmation hearings
Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor, and Pensions (HELP) Committee confirmation hearing on Capitol Hill in Washington, U.S., Jan. 30, 2025. Nathan Howard | Reuters Robert F. Kennedy Jr., President Donald Trump’s pick to lead the Department of […]
Read More
We’re cutting our price target on Danaher as frustration mounts after a messy quarter
Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is further testing our patience. Revenue for the three months ended Dec. 31 advanced 2% year over year on a reported basis, to $6.54 billion, outpacing the LSEG […]
Read More
Watch live: RFK Jr. testifies at Senate confirmation hearing for HHS secretary
[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.] Robert F. Kennedy, President Donald Trump’s controversial pick to lead the Department of Health and Human Services, is testifying on Wednesday before a Senate panel that is crucial to advance […]
Read More
FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat Type 2 diabetes. The FDA’s decision means Ozempic can now […]
Read More
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on […]
Read More